HF
LABD icon

HRT Financial’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

HRT Financial’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,834
Closed -$276K – 3626
2025
Q3 		$276K Buy
6,834
+2,666
+64% +$154K ﹤0.01% 2224
2025
Q2 		$311K Sell
4,168
-5,019
-55% -$444K ﹤0.01% 1831
2025
Q1 		$866K Buy
9,187
+7,457
+431% +$546K 0.01% 1170
2024
Q4 		$125K Sell
1,730
-261,608
-99% -$16M ﹤0.01% 2016
2024
Q3 		$15.4M Buy
263,338
+209,029
+385% +$12.7M 0.08% 168
2024
Q2 		$3.98M Buy
+54,309
New +$4.58M 0.02% 471
2024
Q1 		– Sell
-239,311
Closed -$23.2M – 2726
2023
Q4 		$23.2M Buy
239,311
+231,795
+3,084% +$45.1M 0.17% 57
2023
Q3 		$1.55M Sell
7,516
-47,965
-86% -$7.79M 0.02% 736
2023
Q2 		$7.97M Buy
55,481
+40,163
+262% +$6M 0.07% 184
2023
Q1 		$3.16M Buy
15,318
+3,007
+24% +$511K 0.04% 415
2022
Q4 		$2.12M Sell
12,311
-10,529
-46% -$2.16M 0.03% 561
2022
Q3 		$5.47M Buy
22,840
+13,489
+144% +$3.13M 0.06% 271
2022
Q2 		$3.64M Sell
9,351
-5,213
-36% -$2.61M 0.04% 343
2022
Q1 		$5.11M Buy
14,564
+11,839
+434% +$4.64M 0.04% 285
2021
Q4 		$701K Sell
2,725
-4,356
-62% -$1M ﹤0.01% 1501
2021
Q3 		$1.51M Buy
7,081
+1,969
+39% +$419K 0.01% 938
2021
Q2 		$986K Buy
+5,112
New +$1.15M 0.01% 1143
2021
Q1 		– Sell
-4,297
Closed -$1.08M – 2931
2020
Q4 		$1.08M Buy
+4,297
New +$1.64M 0.02% 580
2020
Q3 		– Sell
-2,069
Closed -$1.44M – 2149
2020
Q2 		$1.44M Buy
+2,069
New +$2.6M 0.04% 431
2020
Q1 		– Sell
-873
Closed -$2.15M – 1087
2019
Q4 		$2.15M Buy
873
+415
+91% +$1.47M 0.09% 174
2019
Q3 		$2.32M Buy
458
+375
+452% +$1.54M 0.11% 146
2019
Q2 		$298K Buy
+83
New +$350K 0.02% 541
2018
Q4 		– Sell
-259
Closed -$1.26M – 681
2018
Q3 		$1.26M Buy
259
+219
+548% +$1.06M 0.2% 86
2018
Q2 		$209K Buy
+40
New +$243K 0.08% 202
2018
Q1 		– Sell
-20
Closed -$181K – 232
2017
Q4 		$181K Buy
20
+2
+11% +$19.9K 0.18% 86
2017
Q3 		$169K Buy
18
+7
+64% +$84.4K 0.21% 76
2017
Q2 		$155K Buy
+11
New +$211K 0.25% 52
2017
Q1 		– Sell
-9
Closed -$340K – 147
2016
Q4 		$340K Buy
+9
New +$346K 0.43% 36

Other funds holding LABD

JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial's LABD Position: Q4 2025 in Review

HRT Financial sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2025, closing a stake of 6,834 shares — an estimated $276K sold.

HRT Financial first reported a position in LABD in Q4 2016 and held it in 28 quarters. The position peaked at $23.2M in Q4 2023. 17 funds tracked by Wall St. Rank hold LABD as of Q4 2025.

  • HRT Financial reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 6,834 Direxion Daily S&P Biotech Bear 3X ETF shares in Q4 2025, an estimated $276K.
  • HRT Financial first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2016 and held it in 28 quarters.
  • HRT Financial's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $23.2M in Q4 2023.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.